Incorporated in 1991, Krebs Biochemicals & Industries Ltd is presently engaged in manufacturing of active pharmaceutical ingredients.
Financial Results:
- Krebs Biochemicals & Industries Ltd reported Revenues for Q1FY24 of ₹10.58 Crores down from ₹10.64 Crore year on year, a fall of 0.56%.
- Total Expenses for Q1FY24 of ₹15.95 Crores down from ₹18.90 Crores year on year, a fall of 15.61%.
- Consolidated Net Profit of -₹5.33 Crores from -₹8.14 Crores in the same quarter of the previous year.
- The Earnings per Share is -₹2.47, from -₹3.78 in the same quarter of the previous year.